Scipher Medicine (US)

https://www.sciphermedicine.com

LinkedIn: https://www.linkedin.com/company/sciphermedicine

Scipher Medicine, a precision immunology company, holds the fundamental belief that patients deserve simple answers to treatment options based on scientifically backed data. Leveraging our proprietary Network Medicine platform and artificial intelligence, we commercialize blood tests identifying a patient’s unique molecular disease signature and match such signature to most effective therapy ensuring patients receive optimal treatment from day one. The unprecedented amount of patient molecular data generated from our tests further drives development of novel and more effective therapeutics. We partner with payers, providers and pharma along the health care value chain to bring precision medicine to autoimmune diseases. Scipher Medicine is backed by Khosla Ventures, Northpond Ventures and UnitedHealth Group. *

	Start	2015-01-01 established
	Industry	Network Medicine Platform
	Industry 2	personalised medicine / precision medicine
	Person	Saleh, Alif (Scipher Medicine 202008 CEO)

	Region	Waltham, MA
	Country	United States (USA)
	Street	260 Charles Street 301
	City	02453 Waltham, MA
		Address record changed: 2024-01-05

Basic data	Employees	n. a.

		* Document for »About Section«: Galapagos N.V.. (8/12/20). "Press Release: Scipher Medicine and Galapagos Sign Collaboration in Inflammatory Bowel Disease". Mechelen & Boston, MA.

		Record changed: 2023-11-27